APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duloxetine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Duloxetine Industry Growth and Trends Forecast to 2032

22 December 2025103 pages

Choose your research edition.

Industry ResearchDuloxetine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Duloxetine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Duloxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duloxetine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Duloxetine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Duloxetine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Duloxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Duloxetine market include Teva, Sun Pharma, Eli Lilly, Zydus Pharmaceuticals, Jiangsu Nhwa Pharmaceutical, Torrent Pharmaceuticals, MACLEODS, Lupin and CSPC Ouyi Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Duloxetine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Duloxetine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Duloxetine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Duloxetine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Duloxetine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Duloxetine Market by Company

Teva

Sun Pharma

Eli Lilly

Zydus Pharmaceuticals

Jiangsu Nhwa Pharmaceutical

Torrent Pharmaceuticals

MACLEODS

Lupin

CSPC Ouyi Pharm

Breckenridge

Aurobindo Pharma

Apotex

Ajanta Pharma

Duloxetine Segment by Type

60mg Capsules

40mg Capsules

30mg Capsules

20mg Capsules

Duloxetine Segment by Application

Hospital

Drug store

Duloxetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duloxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duloxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duloxetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Duloxetine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Duloxetine Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Duloxetine Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Duloxetine Market Share by Region (2021-2026) Table 4. Global Duloxetine Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Duloxetine Market Share by Region (2027-2032) Table 6. Global Duloxetine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Duloxetine Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Duloxetine Market Size Share by Type (2021-2026) Table 9. Global Duloxetine Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Duloxetine Market Size Share Forecasted by Type (2027-2032) Table 11. North America Duloxetine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Duloxetine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Duloxetine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Duloxetine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Duloxetine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Duloxetine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Duloxetine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Duloxetine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Duloxetine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Duloxetine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Duloxetine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Duloxetine Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Duloxetine Market Size Share by Application (2021-2026) Table 24. Global Duloxetine Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Duloxetine Market Size Share Forecasted by Application (2027-2032) Table 26. North America Duloxetine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Duloxetine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Duloxetine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Duloxetine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Duloxetine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Duloxetine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Duloxetine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Duloxetine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Duloxetine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Duloxetine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Duloxetine Industry Trends Table 37. Duloxetine Industry Drivers Table 38. Duloxetine Industry Opportunities and Challenges Table 39. Duloxetine Industry Restraints Table 40. Global Duloxetine Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Duloxetine Revenue Market Share by Company (2021-2026) Table 42. Global Duloxetine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Duloxetine Key Company Headquarters & Area Served Table 44. Global Duloxetine Company, Product Type & Application Table 45. Global Duloxetine Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Duloxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Duloxetine Product Portfolio Table 52. Teva Recent Development Table 53. Sun Pharma Company Information Table 54. Sun Pharma Business Overview Table 55. Sun Pharma Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sun Pharma Duloxetine Product Portfolio Table 57. Sun Pharma Recent Development Table 58. Eli Lilly Company Information Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Eli Lilly Duloxetine Product Portfolio Table 62. Eli Lilly Recent Development Table 63. Zydus Pharmaceuticals Company Information Table 64. Zydus Pharmaceuticals Business Overview Table 65. Zydus Pharmaceuticals Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Zydus Pharmaceuticals Duloxetine Product Portfolio Table 67. Zydus Pharmaceuticals Recent Development Table 68. Jiangsu Nhwa Pharmaceutical Company Information Table 69. Jiangsu Nhwa Pharmaceutical Business Overview Table 70. Jiangsu Nhwa Pharmaceutical Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Jiangsu Nhwa Pharmaceutical Duloxetine Product Portfolio Table 72. Jiangsu Nhwa Pharmaceutical Recent Development Table 73. Torrent Pharmaceuticals Company Information Table 74. Torrent Pharmaceuticals Business Overview Table 75. Torrent Pharmaceuticals Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Torrent Pharmaceuticals Duloxetine Product Portfolio Table 77. Torrent Pharmaceuticals Recent Development Table 78. MACLEODS Company Information Table 79. MACLEODS Business Overview Table 80. MACLEODS Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. MACLEODS Duloxetine Product Portfolio Table 82. MACLEODS Recent Development Table 83. Lupin Company Information Table 84. Lupin Business Overview Table 85. Lupin Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Lupin Duloxetine Product Portfolio Table 87. Lupin Recent Development Table 88. CSPC Ouyi Pharm Company Information Table 89. CSPC Ouyi Pharm Business Overview Table 90. CSPC Ouyi Pharm Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. CSPC Ouyi Pharm Duloxetine Product Portfolio Table 92. CSPC Ouyi Pharm Recent Development Table 93. Breckenridge Company Information Table 94. Breckenridge Business Overview Table 95. Breckenridge Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Breckenridge Duloxetine Product Portfolio Table 97. Breckenridge Recent Development Table 98. Aurobindo Pharma Company Information Table 99. Aurobindo Pharma Business Overview Table 100. Aurobindo Pharma Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Aurobindo Pharma Duloxetine Product Portfolio Table 102. Aurobindo Pharma Recent Development Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Apotex Duloxetine Product Portfolio Table 107. Apotex Recent Development Table 108. Ajanta Pharma Company Information Table 109. Ajanta Pharma Business Overview Table 110. Ajanta Pharma Duloxetine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Ajanta Pharma Duloxetine Product Portfolio Table 112. Ajanta Pharma Recent Development Table 113. North America Duloxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Duloxetine Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Duloxetine Market Share by Country (2021-2026) Table 116. North America Duloxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Duloxetine Market Share Forecast by Country (2027-2032) Table 118. Europe Duloxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Duloxetine Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Duloxetine Market Share by Country (2021-2026) Table 121. Europe Duloxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Duloxetine Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Duloxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Duloxetine Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Duloxetine Market Share by Country (2021-2026) Table 126. Asia-Pacific Duloxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Duloxetine Market Share Forecast by Country (2027-2032) Table 128. Latin America Duloxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Duloxetine Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Duloxetine Market Share by Country (2021-2026) Table 131. Latin America Duloxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Duloxetine Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Duloxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Duloxetine Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Duloxetine Market Share by Country (2021-2026) Table 136. Middle East & Africa Duloxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Duloxetine Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Duloxetine Product Image Figure 3. Global Duloxetine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Duloxetine Market Size (2021-2032) & (US$ Million) Figure 5. Global Duloxetine Market Share by Region: 2025 VS 2032 Figure 6. Global Duloxetine Market Share by Region (2021-2032) Figure 7. North America Duloxetine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Duloxetine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Duloxetine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Duloxetine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Duloxetine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 60mg Capsules Image Figure 13. Global 60mg Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. 40mg Capsules Image Figure 15. Global 40mg Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. 30mg Capsules Image Figure 17. Global 30mg Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. 20mg Capsules Image Figure 19. Global 20mg Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Duloxetine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Duloxetine Market Share by Type 2025 VS 2032 Figure 22. North America Duloxetine Market Size Share by Type (2021-2032) Figure 23. Europe Duloxetine Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Duloxetine Market Size Share by Type (2021-2032) Figure 25. Latin America Duloxetine Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Duloxetine Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Drug store Image Figure 30. Global Drug store Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Duloxetine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Duloxetine Market Share by Application 2025 VS 2032 Figure 33. North America Duloxetine Market Size Share by Application (2021-2032) Figure 34. Europe Duloxetine Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Duloxetine Market Size Share by Application (2021-2032) Figure 36. Latin America Duloxetine Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Duloxetine Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Duloxetine Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Duloxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Duloxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Duloxetine Market Share by Country (2021-2032) Figure 43. Europe Duloxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Duloxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Duloxetine Market Share by Country (2021-2032) Figure 46. Asia-Pacific Duloxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Duloxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Duloxetine Market Share by Country (2021-2032) Figure 49. Latin America Duloxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Duloxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Duloxetine Market Share by Country (2021-2032) Figure 52. Middle East & Africa Duloxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Duloxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Duloxetine Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • 60mg Capsules
  • 40mg Capsules
  • 30mg Capsules
  • 20mg Capsules
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Sun Pharma
  • Eli Lilly
  • Zydus Pharmaceuticals
  • Jiangsu Nhwa Pharmaceutical
  • Torrent Pharmaceuticals
  • MACLEODS
  • Lupin
  • CSPC Ouyi Pharm
  • Breckenridge
  • Aurobindo Pharma
  • Apotex
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Duloxetine Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Duloxetine Market Size by Region (2021-2032)
  5. 1.4.1 Global Duloxetine Market Size by Region (2021-2026)
  6. 1.4.2 Global Duloxetine Market Size by Region (2027-2032)
  7. 1.5 Key Regions Duloxetine Market Size (2021-2032)
  8. 1.5.1 North America Duloxetine Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Duloxetine Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Duloxetine Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Duloxetine Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Duloxetine Market Size Growth Rate (2021-2032)
2 Duloxetine Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 60mg Capsules
  3. 2.1.2 40mg Capsules
  4. 2.1.3 30mg Capsules
  5. 2.1.4 20mg Capsules
  6. 2.2 Global Duloxetine Market Size by Type
  7. 2.2.1 Global Duloxetine Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Duloxetine Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Duloxetine Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Duloxetine Market Size by Regions
  11. 2.3.1 North America Duloxetine Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Duloxetine Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Duloxetine Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Duloxetine Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Duloxetine Market Size Breakdown by Type (2021-2026)
3 Duloxetine Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Drug store
  4. 3.2 Global Duloxetine Market Size by Application
  5. 3.2.1 Global Duloxetine Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Duloxetine Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Duloxetine Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Duloxetine Market Size by Regions
  9. 3.3.1 North America Duloxetine Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Duloxetine Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Duloxetine Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Duloxetine Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Duloxetine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Duloxetine Industry Trends
  2. 4.2 Duloxetine Industry Drivers
  3. 4.3 Duloxetine Industry Opportunities and Challenges
  4. 4.4 Duloxetine Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Duloxetine Revenue (2021-2026)
  2. 5.2 Global Duloxetine Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Duloxetine Key Company Headquarters & Area Served
  4. 5.4 Global Duloxetine Company, Product Type & Application
  5. 5.5 Global Duloxetine Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Duloxetine Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Duloxetine Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Duloxetine Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Duloxetine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharma
  8. 6.2.1 Sun Pharma Company Information
  9. 6.2.2 Sun Pharma Business Overview
  10. 6.2.3 Sun Pharma Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharma Duloxetine Product Portfolio
  12. 6.2.5 Sun Pharma Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Duloxetine Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Zydus Pharmaceuticals
  20. 6.4.1 Zydus Pharmaceuticals Company Information
  21. 6.4.2 Zydus Pharmaceuticals Business Overview
  22. 6.4.3 Zydus Pharmaceuticals Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Pharmaceuticals Duloxetine Product Portfolio
  24. 6.4.5 Zydus Pharmaceuticals Recent Developments
  25. 6.5 Jiangsu Nhwa Pharmaceutical
  26. 6.5.1 Jiangsu Nhwa Pharmaceutical Company Information
  27. 6.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
  28. 6.5.3 Jiangsu Nhwa Pharmaceutical Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Jiangsu Nhwa Pharmaceutical Duloxetine Product Portfolio
  30. 6.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  31. 6.6 Torrent Pharmaceuticals
  32. 6.6.1 Torrent Pharmaceuticals Company Information
  33. 6.6.2 Torrent Pharmaceuticals Business Overview
  34. 6.6.3 Torrent Pharmaceuticals Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Torrent Pharmaceuticals Duloxetine Product Portfolio
  36. 6.6.5 Torrent Pharmaceuticals Recent Developments
  37. 6.7 MACLEODS
  38. 6.7.1 MACLEODS Company Information
  39. 6.7.2 MACLEODS Business Overview
  40. 6.7.3 MACLEODS Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 MACLEODS Duloxetine Product Portfolio
  42. 6.7.5 MACLEODS Recent Developments
  43. 6.8 Lupin
  44. 6.8.1 Lupin Company Information
  45. 6.8.2 Lupin Business Overview
  46. 6.8.3 Lupin Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Lupin Duloxetine Product Portfolio
  48. 6.8.5 Lupin Recent Developments
  49. 6.9 CSPC Ouyi Pharm
  50. 6.9.1 CSPC Ouyi Pharm Company Information
  51. 6.9.2 CSPC Ouyi Pharm Business Overview
  52. 6.9.3 CSPC Ouyi Pharm Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 CSPC Ouyi Pharm Duloxetine Product Portfolio
  54. 6.9.5 CSPC Ouyi Pharm Recent Developments
  55. 6.10 Breckenridge
  56. 6.10.1 Breckenridge Company Information
  57. 6.10.2 Breckenridge Business Overview
  58. 6.10.3 Breckenridge Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Breckenridge Duloxetine Product Portfolio
  60. 6.10.5 Breckenridge Recent Developments
  61. 6.11 Aurobindo Pharma
  62. 6.11.1 Aurobindo Pharma Company Information
  63. 6.11.2 Aurobindo Pharma Business Overview
  64. 6.11.3 Aurobindo Pharma Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Aurobindo Pharma Duloxetine Product Portfolio
  66. 6.11.5 Aurobindo Pharma Recent Developments
  67. 6.12 Apotex
  68. 6.12.1 Apotex Company Information
  69. 6.12.2 Apotex Business Overview
  70. 6.12.3 Apotex Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Apotex Duloxetine Product Portfolio
  72. 6.12.5 Apotex Recent Developments
  73. 6.13 Ajanta Pharma
  74. 6.13.1 Ajanta Pharma Company Information
  75. 6.13.2 Ajanta Pharma Business Overview
  76. 6.13.3 Ajanta Pharma Duloxetine Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Ajanta Pharma Duloxetine Product Portfolio
  78. 6.13.5 Ajanta Pharma Recent Developments
7 North America
  1. 7.1 North America Duloxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Duloxetine Market Size by Country (2021-2026)
  3. 7.3 North America Duloxetine Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Duloxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Duloxetine Market Size by Country (2021-2026)
  3. 8.3 Europe Duloxetine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Duloxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Duloxetine Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Duloxetine Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Duloxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Duloxetine Market Size by Country (2021-2026)
  3. 10.3 South America Duloxetine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Duloxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Duloxetine Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Duloxetine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst